nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP1A2—Fluorouracil—head and neck cancer	0.0502	0.359	CbGbCtD
Zileuton—CYP2C9—Fluorouracil—head and neck cancer	0.0452	0.323	CbGbCtD
Zileuton—CYP3A4—Vinblastine—head and neck cancer	0.0244	0.174	CbGbCtD
Zileuton—CYP3A4—Docetaxel—head and neck cancer	0.0201	0.144	CbGbCtD
Zileuton—Tiaprofenic acid—PTGS2—head and neck cancer	0.012	1	CrCbGaD
Zileuton—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00936	0.0541	CcSEcCtD
Zileuton—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00556	0.0321	CcSEcCtD
Zileuton—Laryngeal pain—Docetaxel—head and neck cancer	0.00551	0.0318	CcSEcCtD
Zileuton—Liver disorder—Docetaxel—head and neck cancer	0.00551	0.0318	CcSEcCtD
Zileuton—Hepatotoxicity—Docetaxel—head and neck cancer	0.00486	0.0281	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00413	0.0238	CcSEcCtD
Zileuton—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00349	0.00518	CbGpPWpGaD
Zileuton—UGT1A9—PPAR Alpha Pathway—CCND1—head and neck cancer	0.00348	0.00515	CbGpPWpGaD
Zileuton—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.00342	0.00507	CbGpPWpGaD
Zileuton—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00335	0.00497	CbGpPWpGaD
Zileuton—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.00334	0.00495	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00329	0.00488	CbGpPWpGaD
Zileuton—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00329	0.00487	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—KISS1—head and neck cancer	0.00323	0.00478	CbGpPWpGaD
Zileuton—Ill-defined disorder—Vinblastine—head and neck cancer	0.00321	0.0186	CcSEcCtD
Zileuton—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.00318	0.00471	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00316	0.00468	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00313	0.00463	CbGpPWpGaD
Zileuton—Malaise—Vinblastine—head and neck cancer	0.00312	0.018	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—NAT2—head and neck cancer	0.00305	0.00452	CbGpPWpGaD
Zileuton—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00303	0.0175	CcSEcCtD
Zileuton—UGT1A9—Metapathway biotransformation—NAT2—head and neck cancer	0.00301	0.00445	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFA—head and neck cancer	0.00296	0.00438	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KISS1—head and neck cancer	0.00293	0.00435	CbGpPWpGaD
Zileuton—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00293	0.0169	CcSEcCtD
Zileuton—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00292	0.00433	CbGpPWpGaD
Zileuton—Discomfort—Vinblastine—head and neck cancer	0.00291	0.0168	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MAPK3—head and neck cancer	0.00289	0.00428	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00288	0.00427	CbGpPWpGaD
Zileuton—Malaise—Hydroxyurea—head and neck cancer	0.00285	0.0165	CcSEcCtD
Zileuton—Conjunctivitis—Fluorouracil—head and neck cancer	0.00283	0.0163	CcSEcCtD
Zileuton—Urinary tract infection—Fluorouracil—head and neck cancer	0.00283	0.0163	CcSEcCtD
Zileuton—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00281	0.00416	CbGpPWpGaD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.0028	0.00414	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—MAPK1—head and neck cancer	0.00275	0.00407	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—EGFR—head and neck cancer	0.00275	0.00407	CbGpPWpGaD
Zileuton—Sinusitis—Fluorouracil—head and neck cancer	0.00273	0.0158	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00273	0.00404	CbGpPWpGaD
Zileuton—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.0027	0.004	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—GRP—head and neck cancer	0.00266	0.00394	CbGpPWpGaD
Zileuton—Discomfort—Hydroxyurea—head and neck cancer	0.00266	0.0153	CcSEcCtD
Zileuton—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00259	0.00384	CbGpPWpGaD
Zileuton—UGT1A9—Phase II conjugation—GSTM1—head and neck cancer	0.00257	0.00381	CbGpPWpGaD
Zileuton—Abdominal pain upper—Docetaxel—head and neck cancer	0.00249	0.0144	CcSEcCtD
Zileuton—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.00249	0.00368	CbGpPWpGaD
Zileuton—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00245	0.00364	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00245	0.00362	CbGpPWpGaD
Zileuton—Constipation—Vinblastine—head and neck cancer	0.00242	0.014	CcSEcCtD
Zileuton—Pain—Vinblastine—head and neck cancer	0.00242	0.014	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—GRP—head and neck cancer	0.00242	0.00358	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—UROD—head and neck cancer	0.00236	0.0035	CbGpPWpGaD
Zileuton—Feeling abnormal—Vinblastine—head and neck cancer	0.00233	0.0135	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TP53—head and neck cancer	0.00231	0.00342	CbGpPWpGaD
Zileuton—Somnolence—Hydroxyurea—head and neck cancer	0.00229	0.0132	CcSEcCtD
Zileuton—Dyspepsia—Hydroxyurea—head and neck cancer	0.00227	0.0131	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00226	0.00335	CbGpPWpGaD
Zileuton—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00226	0.00334	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00223	0.0129	CcSEcCtD
Zileuton—Pain—Hydroxyurea—head and neck cancer	0.0022	0.0127	CcSEcCtD
Zileuton—Constipation—Hydroxyurea—head and neck cancer	0.0022	0.0127	CcSEcCtD
Zileuton—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00219	0.00324	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00217	0.00322	CbGpPWpGaD
Zileuton—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00217	0.00321	CbGpPWpGaD
Zileuton—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00212	0.0123	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00211	0.00312	CbGpPWpGaD
Zileuton—Hypersensitivity—Vinblastine—head and neck cancer	0.00208	0.012	CcSEcCtD
Zileuton—Jaundice—Docetaxel—head and neck cancer	0.00205	0.0118	CcSEcCtD
Zileuton—UGT1A9—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00204	0.00302	CbGpPWpGaD
Zileuton—Conjunctivitis—Docetaxel—head and neck cancer	0.00204	0.0118	CcSEcCtD
Zileuton—Body temperature increased—Hydroxyurea—head and neck cancer	0.00204	0.0118	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00201	0.00298	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.002	0.00296	CbGpPWpGaD
Zileuton—Myalgia—Fluorouracil—head and neck cancer	0.00194	0.0112	CcSEcCtD
Zileuton—Chest pain—Fluorouracil—head and neck cancer	0.00194	0.0112	CcSEcCtD
Zileuton—Diarrhoea—Vinblastine—head and neck cancer	0.00193	0.0112	CcSEcCtD
Zileuton—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00191	0.00283	CbGpPWpGaD
Zileuton—Discomfort—Fluorouracil—head and neck cancer	0.00191	0.011	CcSEcCtD
Zileuton—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.00191	0.00283	CbGpPWpGaD
Zileuton—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0019	0.011	CcSEcCtD
Zileuton—Hepatitis—Docetaxel—head and neck cancer	0.00188	0.0109	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00187	0.00277	CbGpPWpGaD
Zileuton—Dizziness—Vinblastine—head and neck cancer	0.00187	0.0108	CcSEcCtD
Zileuton—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00186	0.00275	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00185	0.00274	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00183	0.00271	CbGpPWpGaD
Zileuton—Vomiting—Vinblastine—head and neck cancer	0.0018	0.0104	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00179	0.00265	CbGpPWpGaD
Zileuton—Headache—Vinblastine—head and neck cancer	0.00177	0.0102	CcSEcCtD
Zileuton—Diarrhoea—Hydroxyurea—head and neck cancer	0.00176	0.0102	CcSEcCtD
Zileuton—EPHX2—Metabolism—NAT2—head and neck cancer	0.00176	0.00261	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KISS1—head and neck cancer	0.00173	0.00257	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00173	0.00256	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—GSTM1—head and neck cancer	0.00172	0.00254	CbGpPWpGaD
Zileuton—Dizziness—Hydroxyurea—head and neck cancer	0.0017	0.00985	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.0017	0.00252	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.0017	0.00252	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00169	0.00977	CcSEcCtD
Zileuton—Nausea—Vinblastine—head and neck cancer	0.00168	0.0097	CcSEcCtD
Zileuton—Insomnia—Fluorouracil—head and neck cancer	0.00168	0.0097	CcSEcCtD
Zileuton—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00166	0.00246	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00165	0.00245	CbGpPWpGaD
Zileuton—Somnolence—Fluorouracil—head and neck cancer	0.00165	0.00953	CcSEcCtD
Zileuton—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00164	0.00243	CbGpPWpGaD
Zileuton—Vomiting—Hydroxyurea—head and neck cancer	0.00164	0.00947	CcSEcCtD
Zileuton—Dyspepsia—Fluorouracil—head and neck cancer	0.00163	0.00944	CcSEcCtD
Zileuton—Rash—Hydroxyurea—head and neck cancer	0.00162	0.00939	CcSEcCtD
Zileuton—Dermatitis—Hydroxyurea—head and neck cancer	0.00162	0.00938	CcSEcCtD
Zileuton—Headache—Hydroxyurea—head and neck cancer	0.00161	0.00933	CcSEcCtD
Zileuton—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0016	0.00925	CcSEcCtD
Zileuton—Pain—Fluorouracil—head and neck cancer	0.00159	0.00917	CcSEcCtD
Zileuton—EPHX2—Metabolism—DPYD—head and neck cancer	0.00155	0.00229	CbGpPWpGaD
Zileuton—Nausea—Hydroxyurea—head and neck cancer	0.00153	0.00885	CcSEcCtD
Zileuton—Feeling abnormal—Fluorouracil—head and neck cancer	0.00153	0.00883	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.00151	0.00223	CbGpPWpGaD
Zileuton—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0015	0.00222	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.0015	0.00222	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.0015	0.00222	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.00149	0.0022	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00148	0.00219	CbGpPWpGaD
Zileuton—Urticaria—Fluorouracil—head and neck cancer	0.00147	0.00852	CcSEcCtD
Zileuton—Body temperature increased—Fluorouracil—head and neck cancer	0.00147	0.00847	CcSEcCtD
Zileuton—EPHX2—Metabolism—YAP1—head and neck cancer	0.00147	0.00217	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.00143	0.00211	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GRP—head and neck cancer	0.00143	0.00211	CbGpPWpGaD
Zileuton—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00142	0.0021	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00142	0.0021	CbGpPWpGaD
Zileuton—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00141	0.00209	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.0014	0.00208	CbGpPWpGaD
Zileuton—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0014	0.00208	CbGpPWpGaD
Zileuton—Chest pain—Docetaxel—head and neck cancer	0.0014	0.00807	CcSEcCtD
Zileuton—Myalgia—Docetaxel—head and neck cancer	0.0014	0.00807	CcSEcCtD
Zileuton—Arthralgia—Docetaxel—head and neck cancer	0.0014	0.00807	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—STAT6—head and neck cancer	0.00139	0.00205	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.00138	0.00204	CbGpPWpGaD
Zileuton—Hypersensitivity—Fluorouracil—head and neck cancer	0.00137	0.0079	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00137	0.00202	CbGpPWpGaD
Zileuton—Pruritus—Fluorouracil—head and neck cancer	0.00131	0.00758	CcSEcCtD
Zileuton—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00131	0.00194	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.00129	0.00191	CbGpPWpGaD
Zileuton—Diarrhoea—Fluorouracil—head and neck cancer	0.00127	0.00733	CcSEcCtD
Zileuton—UGT1A9—Metabolism—UROD—head and neck cancer	0.00126	0.00186	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.00123	0.00182	CbGpPWpGaD
Zileuton—Dizziness—Fluorouracil—head and neck cancer	0.00123	0.00709	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—YAP1—head and neck cancer	0.00123	0.00182	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00122	0.00705	CcSEcCtD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00121	0.0018	CbGpPWpGaD
Zileuton—Insomnia—Docetaxel—head and neck cancer	0.00121	0.007	CcSEcCtD
Zileuton—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0012	0.00177	CbGpPWpGaD
Zileuton—Somnolence—Docetaxel—head and neck cancer	0.00119	0.00688	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00118	0.00175	CbGpPWpGaD
Zileuton—Vomiting—Fluorouracil—head and neck cancer	0.00118	0.00682	CcSEcCtD
Zileuton—Dyspepsia—Docetaxel—head and neck cancer	0.00118	0.00681	CcSEcCtD
Zileuton—Rash—Fluorouracil—head and neck cancer	0.00117	0.00676	CcSEcCtD
Zileuton—Dermatitis—Fluorouracil—head and neck cancer	0.00117	0.00675	CcSEcCtD
Zileuton—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.00116	0.00172	CbGpPWpGaD
Zileuton—Headache—Fluorouracil—head and neck cancer	0.00116	0.00672	CcSEcCtD
Zileuton—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00116	0.00172	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00116	0.00668	CcSEcCtD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00115	0.00171	CbGpPWpGaD
Zileuton—Pain—Docetaxel—head and neck cancer	0.00114	0.00662	CcSEcCtD
Zileuton—Constipation—Docetaxel—head and neck cancer	0.00114	0.00662	CcSEcCtD
Zileuton—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00112	0.00165	CbGpPWpGaD
Zileuton—Feeling abnormal—Docetaxel—head and neck cancer	0.0011	0.00638	CcSEcCtD
Zileuton—Nausea—Fluorouracil—head and neck cancer	0.0011	0.00637	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.0011	0.00163	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.0011	0.00163	CbGpPWpGaD
Zileuton—Body temperature increased—Docetaxel—head and neck cancer	0.00106	0.00612	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00104	0.00154	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00103	0.00153	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—UROD—head and neck cancer	0.00102	0.00152	CbGpPWpGaD
Zileuton—Hypersensitivity—Docetaxel—head and neck cancer	0.000986	0.0057	CcSEcCtD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000984	0.00146	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NAT2—head and neck cancer	0.00098	0.00145	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000977	0.00145	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000974	0.00144	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000961	0.00142	CbGpPWpGaD
Zileuton—Pruritus—Docetaxel—head and neck cancer	0.000947	0.00547	CcSEcCtD
Zileuton—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000943	0.0014	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000937	0.00139	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000925	0.00137	CbGpPWpGaD
Zileuton—Diarrhoea—Docetaxel—head and neck cancer	0.000916	0.00529	CcSEcCtD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000893	0.00132	CbGpPWpGaD
Zileuton—Dizziness—Docetaxel—head and neck cancer	0.000885	0.00512	CcSEcCtD
Zileuton—EPHX2—Metabolism—TYMS—head and neck cancer	0.00088	0.0013	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GSTM1—head and neck cancer	0.00087	0.00129	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000862	0.00128	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—DPYD—head and neck cancer	0.000859	0.00127	CbGpPWpGaD
Zileuton—Vomiting—Docetaxel—head and neck cancer	0.000851	0.00492	CcSEcCtD
Zileuton—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00085	0.00126	CbGpPWpGaD
Zileuton—Rash—Docetaxel—head and neck cancer	0.000844	0.00488	CcSEcCtD
Zileuton—Dermatitis—Docetaxel—head and neck cancer	0.000843	0.00487	CcSEcCtD
Zileuton—Headache—Docetaxel—head and neck cancer	0.000839	0.00485	CcSEcCtD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000835	0.00124	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GPX1—head and neck cancer	0.000833	0.00123	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000828	0.00123	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP1A1—head and neck cancer	0.000825	0.00122	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—YAP1—head and neck cancer	0.000816	0.00121	CbGpPWpGaD
Zileuton—Nausea—Docetaxel—head and neck cancer	0.000795	0.0046	CcSEcCtD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000794	0.00118	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000759	0.00113	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—head and neck cancer	0.000709	0.00105	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000703	0.00104	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000678	0.001	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000645	0.000956	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—head and neck cancer	0.000644	0.000954	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000636	0.000943	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000633	0.000938	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000633	0.000938	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000633	0.000938	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000613	0.000908	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000612	0.000906	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000603	0.000894	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000554	0.00082	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH1—head and neck cancer	0.000553	0.000819	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000551	0.000817	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000548	0.000812	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000544	0.000806	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—UROD—head and neck cancer	0.000538	0.000797	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000534	0.000792	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000523	0.000774	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NAT2—head and neck cancer	0.000521	0.000772	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK3—head and neck cancer	0.000517	0.000767	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000516	0.000764	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000508	0.000753	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK1—head and neck cancer	0.000492	0.000729	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—head and neck cancer	0.000492	0.000729	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—head and neck cancer	0.000491	0.000727	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TYMS—head and neck cancer	0.00049	0.000725	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTM1—head and neck cancer	0.000484	0.000717	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000471	0.000697	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GPX1—head and neck cancer	0.000464	0.000687	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—UROD—head and neck cancer	0.00046	0.000681	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP1A1—head and neck cancer	0.000459	0.00068	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—DPYD—head and neck cancer	0.000457	0.000677	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000451	0.000669	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000447	0.000662	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—YAP1—head and neck cancer	0.000434	0.000643	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—head and neck cancer	0.000428	0.000634	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—head and neck cancer	0.000427	0.000633	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000426	0.00063	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NAT2—head and neck cancer	0.000425	0.00063	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.00042	0.000622	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000417	0.000618	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000403	0.000598	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000398	0.000589	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—HRAS—head and neck cancer	0.000395	0.000586	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AKT1—head and neck cancer	0.000384	0.000569	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—head and neck cancer	0.00038	0.000563	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000377	0.000558	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—DPYD—head and neck cancer	0.000373	0.000552	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCND1—head and neck cancer	0.000371	0.000549	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—head and neck cancer	0.000358	0.00053	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000357	0.000528	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—UROD—head and neck cancer	0.000355	0.000526	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—YAP1—head and neck cancer	0.000354	0.000524	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—head and neck cancer	0.000349	0.000517	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000326	0.000483	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—head and neck cancer	0.000323	0.000479	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—head and neck cancer	0.00032	0.000474	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—head and neck cancer	0.000306	0.000453	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—head and neck cancer	0.000302	0.000447	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK1—head and neck cancer	0.000291	0.000431	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—head and neck cancer	0.000291	0.000431	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000284	0.000421	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—head and neck cancer	0.000273	0.000404	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000266	0.000394	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TYMS—head and neck cancer	0.00026	0.000386	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTM1—head and neck cancer	0.000257	0.000381	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—head and neck cancer	0.000252	0.000374	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GPX1—head and neck cancer	0.000247	0.000365	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—head and neck cancer	0.000247	0.000365	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—head and neck cancer	0.000244	0.000362	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1A1—head and neck cancer	0.000244	0.000362	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—head and neck cancer	0.000238	0.000353	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000237	0.000351	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000235	0.000348	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—head and neck cancer	0.000234	0.000346	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000232	0.000343	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NAT2—head and neck cancer	0.000223	0.000331	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMS—head and neck cancer	0.000212	0.000315	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—head and neck cancer	0.00021	0.000311	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—head and neck cancer	0.000206	0.000305	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000203	0.0003	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPX1—head and neck cancer	0.000201	0.000298	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000201	0.000297	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000201	0.000297	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A1—head and neck cancer	0.000199	0.000295	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DPYD—head and neck cancer	0.000196	0.00029	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NAT2—head and neck cancer	0.000191	0.000283	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—YAP1—head and neck cancer	0.000186	0.000275	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—head and neck cancer	0.000168	0.000249	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DPYD—head and neck cancer	0.000167	0.000248	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000163	0.000242	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—YAP1—head and neck cancer	0.000159	0.000235	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000147	0.000218	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—head and neck cancer	0.000145	0.000215	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00014	0.000207	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—head and neck cancer	0.000137	0.000203	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DPYD—head and neck cancer	0.000129	0.000191	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—head and neck cancer	0.000127	0.000188	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000123	0.000182	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000122	0.00018	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000119	0.000177	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—head and neck cancer	0.000118	0.000175	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMS—head and neck cancer	0.000112	0.000165	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—head and neck cancer	0.00011	0.000163	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPX1—head and neck cancer	0.000106	0.000157	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A1—head and neck cancer	0.000105	0.000155	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000104	0.000154	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—head and neck cancer	0.000103	0.000153	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMS—head and neck cancer	9.54e-05	0.000141	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—head and neck cancer	9.43e-05	0.00014	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX1—head and neck cancer	9.03e-05	0.000134	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1A1—head and neck cancer	8.94e-05	0.000132	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—head and neck cancer	8.93e-05	0.000132	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.59e-05	0.000127	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMS—head and neck cancer	7.36e-05	0.000109	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.34e-05	0.000109	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—head and neck cancer	7.3e-05	0.000108	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—head and neck cancer	7.28e-05	0.000108	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.28e-05	0.000108	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX1—head and neck cancer	6.97e-05	0.000103	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.9e-05	0.000102	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—head and neck cancer	6.22e-05	9.22e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—head and neck cancer	5.95e-05	8.81e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—head and neck cancer	5.43e-05	8.04e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.32e-05	7.87e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—head and neck cancer	4.64e-05	6.87e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.1e-05	6.08e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.83e-05	5.67e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—head and neck cancer	3.58e-05	5.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.27e-05	4.84e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—head and neck cancer	3.13e-05	4.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—head and neck cancer	2.67e-05	3.96e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.52e-05	3.74e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—head and neck cancer	2.06e-05	3.05e-05	CbGpPWpGaD
